Future of the Pharma ADMET Testing Market: Strategic Analysis and Forecast to 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Pharma ADMET Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The pharmaceutical ADMET testing market has observed swift expansion in the past few years. In 2024, it stood at $9.67 billion, and it is set to rise to $10.73 billion in 2025, marking an impressive compound annual growth rate (CAGR) of 10.9%. The historical growth rate is credited to the surge in biosimilars and biopharmaceuticals, an increase in drug development tasks, heightened understanding of drug safety, worldwide outreach of clinical trials, and transition towards in silico modelling.

Pharma ADMET Testing Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the pharma ADMET testing market is anticipated to experience fast-paced growth, eventually reaching a worth of $17.1 billion in 2029 with a CAGR of 12.4%. This predicted growth during the forecasted period can be credited to factors like environmental toxicology, safety assessments, a heightened awareness of pharmacogenomics, a focus on precision medicine, the expansion of biologics and biosimilars market, the integration of artificial intelligence (AI), more extensive regulatory requirements and a surge in orphan drug development. Key trends to expect during this timeframe are an increase in research collaborations, swift technological advancements, progress in analytical technologies, ongoing drug safety monitoring, and considerations on environmental impact.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

What Are the Drivers Transforming the Pharma ADMET Testing Market?
The pharmaceutical ADMET testing market is experiencing growth due to the increasing rate of product approvals. The term 'product approvals' points to the authorization process undertaken by regulatory bodies like the United States' Food and Drug Administration (FDA) or the European Medicines Agency (EMA) in Europe, which allows a product to be retailed and bought by the public. ADMET testing plays a crucial role in ensuring the safety and effectiveness of new products and is a compulsory requirement for product regulatory approvals. For example, the National Library of Medicine, an American biomedical library serving as a national health resource for health professionals, reported in January 2024, a rise in the number of new drugs approved by the FDA from 37 in 2022 to 55 in 2023. Therefore, the pharma ADMET testing market is being propelled by this surge in product approvals.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

What Long-Term Trends Will Define the Future of the Pharma ADMET Testing Market?
Novel product advancements is a significant trend gathering momentum in the pharmaceutical ADMET testing sector. Leading organizations in this field are bringing forward groundbreaking solutions like Logica to maintain their competitive edge. For instance, Charles River Laboratories International Inc., a pharmaceutical company located in the US, in conjunction with Valo Health Inc., a health-tech solution firm from the US, launched Logica, an AI-based remedy development platform in April 2022. This innovative platform harnesses the power of Valo's Opal Computational Platform's AI capabilities to offer ADMET testing services along with other drug delivery solutions. Logica utilizes cutting-edge predictive models, chemical design and synthesis capabilities, DNA coded libraries, and in silico high throughput screening from Valo's Opal Computational Platform. It also capitalizes on Charles River's leading capabilities in comprehensive discovery optimization, including high throughput screening, medicinal chemistry, ADME, biology, pharmacology, ultimately leading to safety testing and IND submission.

Which Segments in the Pharma ADMET Testing Market Offer the Most Profit Potential?
The pharma ADMET testing market covered in this report is segmented -

1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing
2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology
3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

Subsegments:
1) By In Vivo ADMET Testing: Animal Studies, Pharmacokinetics Studies, Toxicology Studies, Biodistribution Studies
2) By In Vitro ADMET Testing: Metabolism Studies, Drug-Drug Interaction Studies, Absorption Studies, Cytotoxicity and Safety Testing
3) By In Silico ADMET Testing: Predictive Modeling and Simulation, Quantitative Structure-Activity Relationship (QSAR) Analysis, Machine Learning Algorithms for ADMET Predictions, Software Tools for ADMET Profiling

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12024&type=smp

Which Firms Dominate the Pharma ADMET Testing Market by Market Share and Revenue in 2025?
Major companies operating in the pharma ADMET testing market include Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.

Which Regions Offer the Highest Growth Potential in the Pharma ADMET Testing Market?
Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma ADMET testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12024

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.